Title:

Commonwealth Biotechnologies, Inc. (CBTE): Drug/Medical Device

Price:$70.00
Publication Date:Jul 28, 2007
Company:Commonwealth Biotechnologies, Inc.
Report Type:Drug/Medical Device Report
Abstract:The most complete and accurate coverage of a company's FDA approved products and pipeline candidates.
Brief Excerpt:...This report examines the Drug/Medical Device pipeline of Commonwealth Biotechnologies, Inc. (CBTE), detailing each drug/device's indication, clinical trial status, and mechanism of action. Furthermore, this report identifies the Focus Sector of CommonwealthBiotechnologies, Inc. (CBTE), and analyzes its pipeline and performance against the Focus Sector to which it belongs. In summary, this Drug/Medical Device Report makes available # key pieces of data that help determine the performance and risk of Biotech, Pharmaceutical and Medical Device companies: (#) product/candidate pipeline, (#) product/candidate clinical trial status, and (#) product/candidate pipeline diversification. ...
Word Count:764
Length:5 Pages
Ticker:CBTE
Exchange:Nasdaq GM
Country:United States
Sector:Outsourced Services
Format:Adobe Acrobat Adobe Acrobat
Free Sample: Click Here to Download

Enter the keyword(s) which you would like to search for within this document and click "Search"

 
Purchase Report
Price: $70.00




Revere Research Reports

Revere Research Reports are a source of valuable information and analysis on topics ranging from healthcare events, competitor overviews, product pipeline analysis and supplier analysis. Data and analytics are based on precise classification and identification of key business relationships for approximately 8,000 publicly traded US companies listed on the US stock exchanges.

  about us contact us public company index private company index pcan widget your privacy rights terms & conditions